Related references
Note: Only part of the references are listed.The cost effectiveness of influenza vaccination for adults aged 50 to 64 years:: A model-based analysis for Spain
Samuel Aballea et al.
VACCINE (2007)
The annual impact of seasonal influenza in the US: Measuring disease burden and costs
Noelle-Angelique M. Molinari et al.
VACCINE (2007)
The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: An international model
Samuel Aballea et al.
VALUE IN HEALTH (2007)
Effectiveness of school-based influenza vaccination
James C. King et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Heterogeneity of case definitions used in vaccine effectiveness studies - And its impact on meta-analysis
Walter E. P. Beyer
VACCINE (2006)
Influenza vaccination - Health impact and cost effectiveness among adults aged 50 to 64 and 65 and older
Michael V. Maciosek et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2006)
Vaccinating healthcare workers against influenza to protect the vulnerable - Is it a good use of healthcare resources? A systematic review of the evidence and an economic evaluation
A Burls et al.
VACCINE (2006)
Influenza vaccination for health-care workers who work with elderly people in institutions: a systematic review
RE Thomas et al.
LANCET INFECTIOUS DISEASES (2006)
Safety of influenza vaccinations administered in nontraditional settings
Sarah J. D'Heilly et al.
VACCINE (2006)
Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors
LA Jackson et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2006)
The cost-effectiveness of influenza vaccination of healthy adults 50-64 years of age
DA Turner et al.
VACCINE (2006)
Where adults reported receiving influenza vaccination in the United States
JA Singleton et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2005)
Colds and influenza-like illnesses in university students: Impact on health, academic and work performance, and health care use
KL Nichol et al.
CLINICAL INFECTIOUS DISEASES (2005)
Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children
PA Piedra et al.
VACCINE (2005)
Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting US employers
RZ Goetzel et al.
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2004)
Influenza-associated hospitalizations in the United States
WW Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Health-related lost productive time (LPT): Recall interval and bias in LPT estimates
WF Stewart et al.
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2004)
Work-site-based influenza vaccination in healthcare and non-healthcare settings
SJ D'Heilly et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2004)
Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine
KL Nichol et al.
VACCINE (2003)
Mortality associated with influenza and respiratory syncytial virus in the United States
WW Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Productivity losses related to the common cold
TJ Bramley et al.
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2002)
The Japanese experience with vaccinating schoolchildren against influenza.
TA Reichert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza
KL Nichol
ARCHIVES OF INTERNAL MEDICINE (2001)
Share Paper
